600 related articles for article (PubMed ID: 19177903)
1. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092
[TBL] [Abstract][Full Text] [Related]
3. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
[TBL] [Abstract][Full Text] [Related]
12. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D
Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characteristics of monostearin nanostructured lipid carriers.
Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
[TBL] [Abstract][Full Text] [Related]
16. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
[TBL] [Abstract][Full Text] [Related]
18. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
Saupe A; Gordon KC; Rades T
Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
[TBL] [Abstract][Full Text] [Related]
19. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
Yuan H; Jiang SP; Du YZ; Miao J; Zhang XG; Hu FQ
Colloids Surf B Biointerfaces; 2009 May; 70(2):248-53. PubMed ID: 19185474
[TBL] [Abstract][Full Text] [Related]
20. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
